Form D · Pharmaceuticals

Aragon Pharmaceuticals, Inc.

San Diego, CA · CIK 0001463270

Offering snapshot reported Sep 25, 2012 · SEC filing

Reported sold
$50M
Offering amount: $50M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 14, 2012
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 25, 2012Initial$49,999,988No comparison9SEC filing
Aug 2, 2012Amendment$37,800,009$100,002vs Mar 7, 20128SEC filing
Mar 7, 2012Initial$37,700,007No comparison7SEC filing
Apr 26, 2010Initial$12,000,001No comparison4SEC filing
May 27, 2009Initial$4,000,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity, Other
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-184610
Securities offered consist of convertible preferred stock and the common stock issuable upon conversion of the preferred stock.

Source: Form D, filed Sep 25, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Adelman Director
Isan Chen Executive
Carol Gallagher Director
Carl Gordon Director
Leo A. Guthart Director
Faheem Hasnain Director
Richard A. Heyman Director, Executive
Peter Svennilson Director
Angie You Executive
Brett Zbar Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
12780 El Camino Real Suite 301
San Diego, CA, 92130